OGEN vs RTX · rev $37.7K vs P/E 36, rev $88.60B
Oragenics Inc (OGEN) versus RTX Corporation (RTX) — a side-by-side from cached financials, not a winner call.
Oragenics Inc (OGEN) is a biotechnology company listed on US.
RTX Corporation (RTX) is a aerospace & defense company listed on NYSE. It is led by Chris Calio.
Latest reported OGEN revenue for 2023-12-31 was $37.7K. Net income was -$20.7M. Revenue was down 71.4% from 2022-12-31 to 2023-12-31. OGEN currently screens at market cap $2.7M.
Latest reported RTX revenue for 2025-12-31 was $88.60B. Net income was $6.73B. Revenue was up 9.7% from 2024-12-31 to 2025-12-31. RTX currently screens at market cap $259.34B and trailing P/E 36.2.
OGEN currently screens at market cap $2.7M. RTX currently screens at market cap $259.34B and trailing P/E 36.2.
Not investment advice. Open the OGEN and RTX stock pages for the full models.
Not investment advice.